Journey Medical Corp (DERM) stock
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)
Close on Nov 17, 2026Market cap $110.08MP/E –Yield –
Journey Medical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Journey Medical's operating income for the twelve months ending Jun 30, 2026 was -$3.01M. For fiscal 2025 it was -$8.17M. The highest annual figure on record is $7.85M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.17M | – |
| FY2024 | Dec 31, 2024 | -$13.68M | – |
| FY2023 | Dec 31, 2023 | -$2.07M | – |
| FY2022 | Dec 31, 2022 | -$27.52M | – |
| FY2021 | Dec 31, 2021 | -$34.88M | -544.3% |
| FY2020 | Dec 31, 2020 | $7.85M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $456.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.49M | – |
| Q4 FY2025 | Dec 31, 2025 | -$443.00K | -119.8% |
| Q3 FY2025 | Sep 30, 2025 | -$1.53M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.88M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.32M | – |
| Q4 FY2024 | Dec 31, 2024 | $2.23M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.89M | -116.8% |
| Q2 FY2024 | Jun 30, 2024 | -$2.93M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.10M | – |
| Q3 FY2023 | Sep 30, 2023 | $17.25M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.49M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.14M | – |
| Q1 FY2022 | Mar 31, 2022 | -$888.00K | -251.8% |
| Q4 FY2021 | Dec 31, 2021 | -$9.06M | -349.8% |
| Q3 FY2021 | Sep 30, 2021 | -$12.65M | -5391.2% |
| Q2 FY2021 | Jun 30, 2021 | -$13.76M | – |
| Q1 FY2021 | Mar 31, 2021 | $585.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $3.63M | – |
| Q3 FY2020 | Sep 30, 2020 | $239.00K | – |
See a number that looks wrong?